Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The committee on Monday awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...